Petra Krhovska

Olomouc, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.

Treatment Patterns and Outcomes in Over 2200 Newly Diagnosed Multiple Myeloma Patients: Supporting Bortezomib-Lenalidomide-Dexamethasone as a Preferred Regimen in the Absence of Anti-CD38 Antibodies.

Journal: Clinical lymphoma, myeloma & leukemia
Published: June 10, 2025

De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis.

De-escalated Teclistamab dosing in relapsed/refractory multiple myeloma: Czech myeloma group real-world evidence analysis.

Journal: Annals of hematology
Published: May 28, 2025

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group.

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group.

Journal: BMC cancer
Published: February 11, 2025

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.

Journal: British journal of haematology
Published: August 06, 2023

Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.

Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy.

Journal: Cancers
Published: September 07, 2022

Bone metabolism parameters and their relation to cytogenetics in multiple myeloma.

Bone metabolism parameters and their relation to cytogenetics in multiple myeloma.

Journal: European journal of haematology
Published: February 07, 2022

Retinal oxygen saturation in monoclonal gammopathies patients: A pilot study.

Retinal oxygen saturation in monoclonal gammopathies patients: A pilot study.

Journal: Acta ophthalmologica
Published: December 18, 2021

Identification of patients at high risk of secondary extramedullary multiple myeloma development.

Identification of patients at high risk of secondary extramedullary multiple myeloma development.

Journal: British journal of haematology
Published: August 17, 2021

COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.

COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.

Journal: Clinical lymphoma, myeloma & leukemia
Published: March 12, 2021

Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.

Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.

Journal: Scientific reports
Published: February 01, 2021

A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma.

A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma.

Journal: Clinical case reports
Published: January 25, 2021

Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.

Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.

Journal: International journal of laboratory hematology
Published: August 17, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026